Correction: UBS Maintains Buy on Teradyne, Raises Price Target to $500

Benzinga Newsdesk www.benzinga.com Positive 86.5%

Neg 0% Neu 0% Pos 86.5%

Correction: UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $440 to $500.